CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine!

被引:1
|
作者
Cook-Sather, Scott D. [1 ]
Adamson, Peter C. [2 ]
Li, Jin [3 ,4 ]
Hakonarson, Hakon [3 ,4 ]
机构
[1] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA
关键词
IMPLEMENTATION CONSORTIUM GUIDELINES; N-DEMETHYLATION; CODEINE THERAPY; S-KETAMINE; PHARMACOGENETICS; GENOTYPES; CYP2B6; ALLELE;
D O I
10.1097/ALN.0000000000001399
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:1085 / 1087
页数:3
相关论文
共 50 条
  • [1] THE EXTENT OF INHIBITION AND INDUCTION OF CYP2B6 BY EFAVRIENZ IS CYP2B6 GENOTYPE-DEPENDENT
    Duong, A.
    Gufford, B.
    Masters, A.
    Burgess, K.
    Lu, J.
    Metzger, I.
    Desta, Z.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S36 - S36
  • [2] Effects of the CYP2B6*6 Allele on Catalytic Properties and Inhibition of CYP2B6 In Vitro: Implication for the Mechanism of Reduced Efavirenz Metabolism and Other CYP2B6 Substrates In Vivo
    Xu, Cong
    Ogburn, Evan T.
    Guo, Yingying
    Desta, Zeruesenay
    [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 717 - 725
  • [3] PharmVar GeneFocus: CYP2B6
    Desta, Zeruesenay
    El-Boraie, Ahmed
    Gong, Li
    Somogyi, Andrew A.
    Lauschke, Volker M.
    Dandara, Collet
    Klein, Kathrin
    Miller, Neil A.
    Klein, Teri E.
    Tyndale, Rachel F.
    Whirl-Carrillo, Michelle
    Gaedigk, Andrea
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (01) : 82 - 97
  • [4] CYP2B6: Inching towards personalized medicine
    Gogtay, N. J.
    [J]. JOURNAL OF POSTGRADUATE MEDICINE, 2012, 58 (04) : 233 - 234
  • [5] Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics
    Saiz-Rodriguez, Miriam
    Ochoa, Dolores
    Roman, Manuel
    Zubiaur, Pablo
    Koller, Dora
    Mejia, Gina
    Abad-Santos, Francisco
    [J]. PHARMACOGENOMICS, 2020, 21 (10) : 663 - 675
  • [6] CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
    Mango, Katalin
    Kiss, Adam Ferenc
    Fekete, Ferenc
    Erdos, Reka
    Monostory, Katalin
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] DEC1 negatively regulates CYP2B6 expression by binding to the CYP2B6 promoter region ascribed to IL-6-induced downregulation of CYP2B6 expression in HeLa cells
    Luan, Xiaofei
    Zhao, Yi
    Bu, Na
    Chen, Yue
    Chen, Nan
    [J]. XENOBIOTICA, 2021, 51 (12) : 1343 - 1351
  • [8] CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
    Katalin Mangó
    Ádám Ferenc Kiss
    Ferenc Fekete
    Réka Erdős
    Katalin Monostory
    [J]. Scientific Reports, 12
  • [9] Bioactivation of chlorpyrifos by CYP2B6 variants
    Crane, Alice L.
    Klein, Kathrin
    Olson, James R.
    [J]. XENOBIOTICA, 2012, 42 (12) : 1255 - 1262
  • [10] Haplotypes frequencies of CYP2B6 in Malaysia
    Musa, N.
    Zulkafli, M., I
    Talib, N.
    Mohamad, N.
    Fauzi, H.
    Ismail, R.
    [J]. JOURNAL OF POSTGRADUATE MEDICINE, 2012, 58 (04) : 235 - 241